Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoko Hagiwara

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 26, 2002
[Guidelines for antiarrhythmic therapy]Yoko Hagiwara, Satoshi Ogawa
Journal of Orthopaedic Science : Official Journal of the Japanese Orthopaedic Association|September 6, 2013
Rotational valgus osteotomy for shepherd's crook deformity: a case reportYoko Hagiwara, Shintaro Iwata, Tsukasa Yonemoto, et al.
Anticancer Research|April 25, 2023
Does Multidisciplinary Therapy at a Sarcoma Center Improve the Prognosis of Patients With Soft Tissue Sarcoma? A Retrospective Case Study at a Single InstituteTsukasa Yonemoto, Hiroto Kamoda, Yoko Hagiwara, et al.
American Journal of Clinical Oncology|October 7, 2003
Marriage and fertility in long-term survivors of high grade osteosarcomaTsukasa Yonemoto, Shin-ichiro Tatezaki, Takeshi Ishii, et al.
American Journal of Clinical Oncology|June 1, 2004
Multiple primary cancers in patients with osteosarcoma: influence of anticancer drugs and genetic factorsTsukasa Yonemoto, Shin-ichiro Tatezaki, Takeshi Ishii, et al.
Cancer Diagnosis & Prognosis|November 7, 2022
Prognostic Factors for Survival in Patients With High-grade ChondrosarcomaHideyuki Kinoshita, Hiroto Kamoda, Yoko Hagiwara, et al.
Anticancer Research|May 31, 2024
The Combination of Auranofin and Celecoxib Suppresses Local Synovial Sarcoma Progression <i>In Vivo</i>Hideyuki Kinoshita, Seiko Kinoshita, Hiroto Kamoda, et al.
Cancer Genomics & Proteomics|February 29, 2024
Thioredoxin Reductase Inhibitor Suppresses the Local Progression of Rhabdomyosarcoma With PDX ModelsHideyuki Kinoshita, Seiko Kinoshita, Hiroto Kamoda, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 1, 2002
[Hepatic osteodystrophy]Kazutomo Suzuki, Tomoko Oki, Rie Oyama, et al.
Anticancer Research|February 29, 2024
Combined Auranofin and Celecoxib Suppresses the Local Progression and Pulmonary Metastases of Osteosarcoma <i>In Vivo</i>Hideyuki Kinoshita, Seiko Kinoshita, Hiroto Kamoda, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 26, 2002
[Guidelines for antiarrhythmic therapy]Yoko Hagiwara, Satoshi Ogawa
Journal of Orthopaedic Science : Official Journal of the Japanese Orthopaedic Association|September 6, 2013
Rotational valgus osteotomy for shepherd's crook deformity: a case reportYoko Hagiwara, Shintaro Iwata, Tsukasa Yonemoto, et al.
Anticancer Research|April 25, 2023
Does Multidisciplinary Therapy at a Sarcoma Center Improve the Prognosis of Patients With Soft Tissue Sarcoma? A Retrospective Case Study at a Single InstituteTsukasa Yonemoto, Hiroto Kamoda, Yoko Hagiwara, et al.
American Journal of Clinical Oncology|October 7, 2003
Marriage and fertility in long-term survivors of high grade osteosarcomaTsukasa Yonemoto, Shin-ichiro Tatezaki, Takeshi Ishii, et al.
American Journal of Clinical Oncology|June 1, 2004
Multiple primary cancers in patients with osteosarcoma: influence of anticancer drugs and genetic factorsTsukasa Yonemoto, Shin-ichiro Tatezaki, Takeshi Ishii, et al.
Cancer Diagnosis & Prognosis|November 7, 2022
Prognostic Factors for Survival in Patients With High-grade ChondrosarcomaHideyuki Kinoshita, Hiroto Kamoda, Yoko Hagiwara, et al.
Anticancer Research|May 31, 2024
The Combination of Auranofin and Celecoxib Suppresses Local Synovial Sarcoma Progression <i>In Vivo</i>Hideyuki Kinoshita, Seiko Kinoshita, Hiroto Kamoda, et al.
Cancer Genomics & Proteomics|February 29, 2024
Thioredoxin Reductase Inhibitor Suppresses the Local Progression of Rhabdomyosarcoma With PDX ModelsHideyuki Kinoshita, Seiko Kinoshita, Hiroto Kamoda, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 1, 2002
[Hepatic osteodystrophy]Kazutomo Suzuki, Tomoko Oki, Rie Oyama, et al.
Anticancer Research|February 29, 2024
Combined Auranofin and Celecoxib Suppresses the Local Progression and Pulmonary Metastases of Osteosarcoma <i>In Vivo</i>Hideyuki Kinoshita, Seiko Kinoshita, Hiroto Kamoda, et al.
Pageof 6